✦ LIBER ✦

A decline in circulating HER2 DNA predicts treatment response and survival in breast cancer patients treated with trastuzumab

✍ Scribed by B. Sorensen; L.S. Mortensen; J. Andersen; E. Nexo

Book ID: 119598829
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 88 KB
Volume: 6
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(08)71600-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Level of HER2 Gene Amplification Predict

Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab

✍ Gomez-Martin, C.; Plaza, J. C.; Pazo-Cid, R.; Salud, A.; Pons, F.; Fonseca, P.; 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 485 KB

Circulating interleukin-6 predicts survi

Circulating interleukin-6 predicts survival in patients with metastatic breast cancer

✍ Roberto Salgado; Sara Junius; Ina Benoy; Peter Van Dam; Peter Vermeulen; Eric Va 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 84 KB 👁 1 views

## Abstract Interleukin‐6 (IL‐6) is a multifunctional cytokine produced by macrophages, T cells, B cells, endothelial cells and tumour cells. Interleukin‐6 is able to promote tumour growth by upregulating anti‐apoptotic and angiogenic proteins in tumour cells. In murine models it has been demonstra

Pathologic Complete Response to Neoadjuv

Pathologic Complete Response to Neoadjuvant Chemotherapy Plus Trastuzumab Predicts for Improved Survival in Women With HER2-positive Breast Cancer

✍ Kim, M.M.; Allen, P.; Gonzalez-Angulo, A.; Woodward, W.A.; Meric-Bernstam, F.; B 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Detection of HER2 amplification in circu

Detection of HER2 amplification in circulating free DNA in patients with breast cancer

✍ Page, K; Hava, N; Ward, B; Brown, J; Guttery, D S; Ruangpratheep, C; Blighe, K; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 417 KB

Clinical utility of serum HER2/neu in mo

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

✍ Francisco J Esteva, Carol D Cheli, Herbert Fritsche… 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 195 KB

Quantitative HER2 protein levels predict

Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab

✍ Allan Lipton; Wolfgang J. Köstler; Kim Leitzel; Suhail M. Ali; Jeff Sperinde; Jo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 492 KB 👁 2 views

## Abstract ## BACKGROUND: Only a portion of breast cancer patients currently selected for trastuzumab therapy respond. ## METHODS: Using a novel assay (HERmark) to quantify total human epidermal growth factor receptor 2 (HER2) expression, the authors examined outcomes in 102 trastuzumab‐treated